Zhenlong (Hong Kong) Limited is  the sole authorized entity of Jiangsu Lianhuan Pharmaceuticals Co., Ltd. to legally export from China and distribute AOLI medical products in over 80 countries across the world.

WANBAOLUO Co., Ltd. is a leading global biopharmaceutical company dedicatedto enhancing human life through the integration of science, technology, and talent. Proudly to introduce our AOLI tadalafil and dapoxetine hydrochloride tables, our vision is to improve the quality of life through innovative medical solutions.

+

——

——

+

——

——

The companywas foundedin December 1999.Successfully listed on the main board of Shanghai Stock Exchange in March 2003.The stock is re-ferred to as “Lianhuan Pharma” and the stock code is 600513.

The companyhas grown into a national high-tech enterprise iintegra-ting R&D, manufacturing and mark-eting, and its products involve organic iintermediates, chemical APIs and chemical finished pharmaceutical dosa-ge forms.The company's annual reve-nue exceeds RMB 2 billion.

Lianhuan Pharma has formed two R&D platforms in Nanjingand Yangzhou bas-ed on ac-ademician workstation and d-octor workstation, and has established good technical cooperation relations wi-th Shanghai Institute of Pharmaceutical Research of Chinese Acade-my of Sci-ences and China Pharma-ceutical Uni-versity, etc.

The company's product portfolio encompass-

es five major therapeutic categories:

1. Urological System

2. Antihistamines

3. Cardiovascular

4. Steroid Hormones

5. Antibiotic

A highly qualified R&D team of over 150 people

consisting of researchers with PhDs and masters degrees.

Lianhuan Pharma has formed two R&D platforms in Nanjing and Yangzhou based on academician workstation and doctor workstation

The company has applied for over 70 domestic

and international invention patents, and has been granted 25 patents

More than 20 people were selected from Subei People's Hospital, Municipal Maternal and Child Health Hospital, Municipal Medicinal Materials Company, and Department Store to form the "Local State owned Yangzhou Pharmaceutical Factory Preparation Office"

The local state-owned Yangzhou Pharmaceutical Factory has been renamed as "China Pharmaceutical Industry Corporation Yangzhou Pharmaceutical Factory" and is managed by China Pharmaceutical Industry Corporation Nanjing Branch (Trust).

Acetyltestosterone was awarded the Jiangsu Province Excellent New Product (Golden Bull Award).

Named as a 'Provincial Advanced Enterprise'.

Yangzhou Pharmaceutical Factory, as the main initiator, jointly established Jiangsu Lianhuan Pharmaceutical Co., Ltd. with Shanghai Lianchuang Investment Management Co., Ltd., China National Pharmaceutical Group Pharmaceutical Co., Ltd. and other enterprises.

The tablet workshop has passed the national GMP on-site certification, and the company has obtained its first GMP certificate.

The company is listed on the Shanghai Stock Exchange (stock code: 600513), with Chairman Yao Xingtian sounding the gong to open the market, raising approximately 150 million yuan.

The company has been rated as a contract abiding and trustworthy enterprise by the Jiangsu Provincial Government. Aprilet and its tablets have been recognized as national key new products by the Ministry of Science and Technology, the Ministry of Commerce, and other departments.

The company has been rated as one of the top 100 pharmaceutical industries in China by the National Food and Drug Administration's "Pharmaceutical Economy News".

The company fully acquired Yangzhou Pharmaceutical Co., Ltd. and was selected as one of the top 100 pharmaceutical industry enterprises in China at the 29th National Pharmaceutical Industry Information Annual Conference.

The company held a groundbreaking ceremony for its new factory area in the Biological Health Industry Park of Yangzhou National High tech Industrial Development Zone.

Our customer base spans across Southeast Asia, Africa, South America, and the Middle East.